Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
The North Dakota supreme court revived the state’s abortion ban on Friday, once again making it...
Cases of infant botulism tied to the ByHeart infant formula recall have nearly tripled across 15...
A federal judge officially approved drug maker Purdue Pharma’s latest deal to settle thousands of lawsuits...
